In recently postmenopausal women, HRT reduced a composite of death, MI, or heart failure at 10 years
After 10 years of randomised treatment, women receiving hormone replacement therapy early after menopause had a significantly reduced risk of mortality, heart failure, or myocardial infarction, without any apparent increase in risk of cancer, venous thromboembolism, or stroke
ACP Journal Club. 2013 Feb 19;158:JC2-2.
Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409. [PubMed ID: 23048011].Web